Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke

• Status: Completed
• Trial end date: 2018-11-27
• Target enrollment: 0
• Participant gender: All

Summary

The objective of the study is to confirm the safety and possible efficacy of Adipose-Tissue Derived Stem Cells treatment of chronic stroke. Specifically, the study will transplant autologous ADSCs into brain surrounding ischemic infarct in adult (65-80 years old) subjects who have chronic non-hemorrhagic stroke (>6 months).

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.

Criteria

Inclusion Criteria:

• stroke investigators with age 65 to 80 years

• history of stroke between six months and 10 years

• Systolic pressure and Diastolic pressure were maintained under 160 mmHg and 110 mmHg

• INR < 2.5, platelets counts 1-5 x 10^5/μl

• Damaged area range between 0.5 cm to 6 cm by brain MRI

Exclusion Criteria:

• Pregnant women

• Investigators with AIDS, cancer, liver dysfunction

• Others can't fit into the trial evaluate by investigator